{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:36:34Z","timestamp":1787283394878,"version":"build-2736575974"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec id=\"ab-eoi260021-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Diabetic retinal neurodegeneration precedes vascular changes associated with diabetic retinal disease (DRD). Studies in adults with type 1 diabetes (T1D) show there is retinal layer thinning with DRD, yet there are limited data in youth with T1D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine if retinal layer thickness changes on optical coherence tomography (OCT) imaging were associated with glycemic outcomes and DRD in youth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective cohort study was conducted at an academic pediatric diabetes center among youth with T1D aged 9 to 21 years participating in the ACCESS2 (AI for Pediatric Diabetic Eye Exams Study 2) study. Participants were enrolled and data were collected July 11, 2022, and April 30, 2025. Data analysis was performed from June 2025 through October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>OCT imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was macular OCT volumes, which were segmented by the Topcon Maestro camera software and reviewed by the Wisconsin Reading Center for 3 neuroretinal layers: (1) retinal nerve fiber layer (RNFL) thickness, (2) ganglion cell and inner plexiform layer (GCL+IPL) thickness, and (3) GCL+IPL+RNFL thickness, as well as total retinal thickness. Layer thicknesses were analyzed for associations with glycemic outcomes and DRD and for potential covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 294 youth with T1D (n\u2009=\u2009578 eyes), among whom mean (SD) age was 15.8 (2.8) years, 153 participants (52.0%) were female, and 108 participants (36.7%) had public insurance, were included. Participants had a median (IQR) duration of diabetes of 7.0 (4.6-10.1) years and a median (IQR) hemoglobin A\n                      <jats:sub>\n                        1\n                        <jats:sc>c<\/jats:sc>\n                      <\/jats:sub>\n                      (HbA\n                      <jats:sub>\n                        1\n                        <jats:sc>c<\/jats:sc>\n                      <\/jats:sub>\n                      ) of 8.5% (7.5%-9.9%); 210 participants (71.4%) used an insulin pump. Of the total 578 eyes, 65 eyes (11.2%) had mild DRD and 10 eyes (1.73%) had moderate DRD. In adjusted analyses, moderate DRD vs no DRD was associated with RNFL thickness of \u22121.2 \u00b5m (95% CI, \u22122.9 to 0.5;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.20), GCL+IPL thickness of \u22121.2 \u00b5m (95% CI, \u22122.8 to 0.4;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.19), and outer retinal layer thickness of \u22120.8 \u00b5m (95% CI, \u22123.9 to 2.2;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.80). In multivariable models, GCL+IPL and outer retinal layer thickness were associated with HbA\n                      <jats:sub>\n                        1\n                        <jats:sc>c<\/jats:sc>\n                      <\/jats:sub>\n                      (\u03b2\u2009=\u2009\u22120.39; 95% CI, \u22120.78 to \u22120.01;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.04; and \u03b2\u2009=\u2009\u22120.81; 95% CI, \u22121.49 to \u22120.12;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.02, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260021-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>\n                      In this prospective cohort study, neuroretinal layer thinning was observed in youth with T1D without clinically apparent DRD and was associated with higher HbA\n                      <jats:sub>\n                        1\n                        <jats:sc>c<\/jats:sc>\n                      <\/jats:sub>\n                      . These findings support elucidating the development of diabetic retinal neurodegeneration and its potential role as a biomarker of retinal vascular disease in youth.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.1341","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:30:25Z","timestamp":1782401425000},"page":"764","source":"Crossref","is-referenced-by-count":1,"title":["Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A\n                    <sub>\n                      1\n                      <scp>c<\/scp>\n                    <\/sub>\n                    in Youth With Type 1 Diabetes"],"prefix":"10.1001","volume":"144","author":[{"given":"Supriya","family":"Ramanujam","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roomasa","family":"Channa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Y. Alvin","family":"Liu","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute at the Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Parimi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoohee Claire","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Bromberger","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold P.","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Section on Biomedical Informatics and Data Science, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Abramoff","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City"},{"name":"Digital Diagnostics, Coralville, Iowa"},{"name":"Iowa City VA Medical Center, Iowa City, Iowa"},{"name":"Department of Biomedical Engineering, The University of Iowa, Iowa City"},{"name":"Department of Electrical and Computer Engineering, The University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa M.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"eoi260021r1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09286580701396720","article-title":"Overview of epidemiologic studies of diabetic retinopathy.","volume":"14","author":"Klein","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"eoi260021r2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.2337\/dc22-2503","article-title":"Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with youth-onset type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study.","volume":"46","author":"Jensen","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"eoi260021r3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes.","volume":"385","author":"Bjornstad","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"eoi260021r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16830","article-title":"Associations between blood pressure levels and diabetic retinopathy in patients with diabetes mellitus: a population-based study.","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"eoi260021r5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005-2008.","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"eoi260021r6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy.","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"eoi260021r7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaophthalmol.2021.5052","article-title":"Ocular sequelae in a population-based cohort of youth diagnosed with diabetes during a 50-year period.","volume":"140","author":"Bai","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"eoi260021r8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jamaophthalmol.2017.0089","article-title":"Ophthalmic screening patterns among youths with diabetes enrolled in a large US managed care network.","volume":"135","author":"Wang","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi260021r9","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jama.1993.03500100088034","article-title":"How effective are treatments for diabetic retinopathy?","volume":"269","author":"Ferris","year":"1993","journal-title":"JAMA"},{"key":"eoi260021r10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","article-title":"Diabetic retinopathy is a neurodegenerative disorder.","volume":"139","author":"Lynch","year":"2017","journal-title":"Vision Res"},{"issue":"9","key":"eoi260021r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257836","article-title":"Detecting retinal neurodegeneration in people with diabetes: findings from the UK Biobank.","volume":"16","author":"Channa","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"eoi260021r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100420","article-title":"A new approach to staging diabetic eye disease: staging of diabetic retinal neurodegeneration and diabetic macular edema.","volume":"4","author":"Channa","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"7","key":"eoi260021r13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1352458509104586","article-title":"Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.","volume":"15","author":"Yeh","year":"2009","journal-title":"Mult Scler"},{"issue":"3","key":"eoi260021r14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.msard.2013.10.008","article-title":"Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.","volume":"3","author":"Waldman","year":"2013","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"eoi260021r15","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/IAE.0000000000001735","article-title":"Handheld spectral domain optical coherence tomography imaging through the undilated pupil in infants born preterm or with hypoxic injury or hydrocephalus.","volume":"38","author":"Tran-Viet","year":"2018","journal-title":"Retina"},{"issue":"5","key":"eoi260021r16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00417-020-04996-y","article-title":"Spectral-domain OCT changes in retina and optic nerve in children with hypoxic-ischaemic encephalopathy.","volume":"259","author":"Grego","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"eoi260021r17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2818.2012.03619.x","article-title":"Optical coherence tomography.","volume":"247","author":"Podoleanu","year":"2012","journal-title":"J Microsc"},{"issue":"10","key":"eoi260021r18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.20452\/pamw.1411","article-title":"Neurodegeneration of the retina in type 1 diabetic patients.","volume":"122","author":"Araszkiewicz","year":"2012","journal-title":"Pol Arch Med Wewn"},{"issue":"19","key":"eoi260021r19","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"eoi260021r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100191","article-title":"Retinal thickness and morphology changes on OCT in youth with type 2 diabetes: findings from the TODAY study.","volume":"2","author":"Mititelu","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"eoi260021r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108420","article-title":"Reduced minimum rim width of optic nerve head: a potential early marker of retinal neurodegeneration in children and adolescents with type 1 diabetes.","volume":"169","author":"Piona","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"eoi260021r22","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.3390\/jcm11143982","article-title":"Retinal microvascular and neuronal changes are also present, even if differently, in adolescents with type 1 diabetes without clinical diabetic retinopathy.","volume":"11","author":"Pilotto","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"eoi260021r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100917","article-title":"OCT angiography of chorioretinal microvasculature in children with type 1 and type 2 diabetes without retinopathy.","volume":"6","author":"Aman","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"eoi260021r24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"eoi260021r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"5","key":"eoi260021r26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/pedi.13037","article-title":"Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.","volume":"21","author":"Porter","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"eoi260021r27","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1167\/iovs.09-5041","article-title":"Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.","volume":"51","author":"van Dijk","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi260021r28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/cxo.12667","article-title":"Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy.","volume":"101","author":"Tekin","year":"2018","journal-title":"Clin Exp Optom"},{"issue":"3","key":"eoi260021r29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/diagnostics9030105","article-title":"The HD-OCT study may be useful in searching for markers of preclinical stage of diabetic retinopathy in patients with type 1 diabetes.","volume":"9","author":"Kolodziej","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"14","key":"eoi260021r30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","article-title":"Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes.","volume":"318","author":"Karges","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"eoi260021r31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1089\/dia.2023.0320","article-title":"Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.","volume":"25","author":"Ebekozien","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"eoi260021r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.26353","article-title":"Trends and disparities in technology use and glycemic control in type 1 diabetes.","volume":"8","author":"Fang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"eoi260021r33","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2337\/dc23-0495","article-title":"Association between diabetes technology use and glycemic outcomes in adults with type 1 diabetes over a decade.","volume":"46","author":"Karakus","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"eoi260021r34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2025-002218","article-title":"Photoreceptor thickness in UK Biobank participants with and without diabetes mellitus.","volume":"10","author":"Schneider","year":"2025","journal-title":"BMJ Open Ophthalmol"},{"issue":"7","key":"eoi260021r35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.ophtha.2020.11.015","article-title":"Retinal nerve fiber layer thickness in healthy eyes of Black, Chinese, and Latino Americans: a population-based multiethnic study.","volume":"128","author":"Nousome","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi260021r36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2009.09.025","article-title":"Retinal thickness analysis by race, gender, and age using Stratus OCT.","volume":"149","author":"Kashani","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi260021r37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1167\/iovs.10-5886","article-title":"Race- and sex-related differences in retinal thickness and foveal pit morphology.","volume":"52","author":"Wagner-Schuman","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi260021r38","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1111\/aos.14273","article-title":"Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?","volume":"98","author":"Gerendas","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"eoi260021r39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-001061","article-title":"Total retinal thickness: a neglected factor in the evaluation of inner retinal thickness.","volume":"7","author":"Banghart","year":"2022","journal-title":"BMJ Open Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2850931\/jamaophthalmology_ramanujam_2026_oi_260021_1787172292.2227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:01:41Z","timestamp":1787238101000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2850931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.1341","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}